Ebenyo wrote:Ericsson wrote:Company was mismanaged by the founding family and then once done they sold majority stake to CDC of UK.
Kazi iendelee.
What is being witnessed in ARM is similar to what Nakumatt is undergoing;difference been Nakumatt is yet to find a strategic investor.
The money from cdc is not reflected here as it was given the other day.Next year results will give a true picture of the company state of health.
The cash injection has been reflected since it came in in 3Q 2016. The full
benefit of the cash doesn't show up but for 4Q. A better FY 2017 can be expected with huge savings on interest costs BUT I would wait for 1H 2017 results to see where this firm might be headed. ARM got into a lot of trouble in the 90s by loading up on debt but was bailed out by Bamburi. This is a repeat.
The sale of non-core businesses may be a good idea to release cash & pay down debt OR boost working capital.
ARM's huge bet on TZ hasn't paid off. Delays in commissioning the plant then the drama with coal supplies and depressed market. TZ isn't a friendly place to do business for Kenyan firms.
Greedy when others are fearful. Very fearful when others are greedy - to paraphrase Warren Buffett